BlackRock Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$231M Sell
10,687,012
-3,539,189
-25% -$77.2M 0.23% 104
2016
Q3
$339M Sell
14,226,201
-2,496,203
-15% -$59.5M 0.35% 69
2016
Q2
$391M Buy
16,722,404
+2,677,033
+19% +$57.9M 0.4% 60
2016
Q1
$264M Buy
14,045,371
+348,351
+3% +$6.12M 0.28% 89
2015
Q4
$253M Buy
13,697,020
+1,155,619
+9% +$20.7M 0.27% 92
2015
Q3
$206M Buy
12,541,401
+2,530,186
+25% +$43.2M 0.22% 114
2015
Q2
$177M Buy
10,011,215
+1,693,674
+20% +$30.3M 0.18% 136
2015
Q1
$148M Buy
8,317,541
+4,359,441
+110% +$68.9M 0.15% 162
2014
Q4
$52.4M Buy
3,958,100
+638,632
+19% +$8.16M 0.05% 328
2014
Q3
$39.2M Sell
3,319,468
-644,054
-16% -$8.11M 0.04% 398
2014
Q2
$50.6M Sell
3,963,522
-1,546,935
-28% -$20.1M 0.05% 352
2014
Q1
$74.5M Sell
5,510,457
-2,443,037
-31% -$32.1M 0.07% 274
2013
Q4
$95.6M Buy
7,953,494
+1,340,426
+20% +$15.8M 0.09% 229
2013
Q3
$77.6M Buy
6,613,068
+1,298,542
+24% +$14M 0.08% 261
2013
Q2
$49.3M Buy
+5,314,526
New +$45.1M 0.05% 320

Other funds holding BSX

BlackRock Advisors's BSX Position: Q4 2016 in Review

BlackRock Advisors reduced its Boston Scientific (BSX) stake by 25% in Q4 2016, selling an estimated $77.2M and leaving 10,687,012 shares worth $231M. The position accounts for 0.23% of the portfolio, ranked #104.

BlackRock Advisors first reported a position in BSX in Q2 2013 and has held it in 15 quarters since. The position peaked at $391M in Q2 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

  • BlackRock Advisors held 10,687,012 shares of Boston Scientific worth $231M as of Q4 2016.
  • BlackRock Advisors sold 3,539,189 Boston Scientific shares in Q4 2016, an estimated $77.2M.
  • Boston Scientific made up 0.23% of BlackRock Advisors's portfolio in Q4 2016, its #104 holding.
  • BlackRock Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Boston Scientific position peaked at $391M in Q2 2016.
  • 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.